Abstract:The large and diverse supra-family of RNA-binding proteins (RBPs) orchestrates the fate of cellular RNAs starting from biosynthesis to decay either
via direct interaction or via ternary formation of ribonucleoprotein (RNP) complexes. Interestingly, recent technical advances allowed for the discovery of hundreds of previously unrecognized RBPs in human cells, with many of such factors surprisingly containing
unconventional, disordered or yet uncharacterized RNA-interacting modules. A substantial number of these RNA-omics studies also revealed the unique human DEK oncoprotein, a conserved factor known to interact with cellular DNA and chromatin, as an RBP. Yet,
the precise RNA interaction domain in DEK remained elusive. A recent study from our research group identified the central region of DEK (amino acids 187-270) as a prominent RNA-interaction domain by employing a newly developed biochemical method, namely Bacterial
Growth Inhibition Screen (BGIS). This domain in DEK appears to be intrinsically disordered and shows no resemblance to any yet known or characterized RNA-interaction domains. Based on these findings, the major aim of this dissertation was to elucidate the
biological role of the DEK-RNA interplay in human cells.
To tackle this task, an “RNA-binding null” mutant, termed RBN#3c, within the lysine-rich region of DEK (amino acids 187-270) was successfully created
by employing BGIS in combination with random mutagenesis. A cross-linking and immunoprecipitation (CLIP) approach was chosen to identify distinct DEK-interacting RNA species. Indeed, using lentivirally-engineered human cell lines inducibly expressing eGFP
fusions of DEK full length and RBN#3c for CLIP-sequencing (CLIP-seq) approaches, various distinct RNA species, encompassing mRNAs, long non-coding RNAs, snoRNAs, snRNAs, miRNAs as well as rRNAs, were identified. Bioinformatics analyses of RNA sequences cross-linked
to DEK revealed that the central RNA-binding region of DEK may predominantly function in pre-mRNA splicing, based on the “purine-rich” identity of RNA transcripts captured. Surprisingly, the C-terminal portion of DEK, also able to interact with RNA, preferentially
binds to the poly(A)-tail of mRNA, suggesting distinct roles of these two RNA-interaction domains in DEK.
Importantly, further detailed bioinformatics analyses of the global RNA target datasets revealed strong overrepresentation of a particular cellular
pathway – ribosome biogenesis, which was somewhat unexpected given the previously known functions of DEK. Indeed, subsequent experimental cytoplasmic ribosome profiling analyses in DEK-depleted cells strongly supported this notion. Specifically, a DEK-dependent
pronounced impairment of the 60S large ribosomal subunit along with substantially reduced global translation efficiency in cells was observed. Importantly, this pronounced deficiency could be rescued by re-expression of Cterminal DEK fragments, yet not N-terminal
fragments or the RBN#3c mutant. Detailed analyses of the ribosome biogenesis pathway using a series of state-of-the-art techniques, including SUrface SEnsing of Translation (SUnSET) assay, Fluorescence In Situ Hybridization (FISH) analyses, Pre-ribosome Sequential
Extraction (PSE) assay, and others, revealed implications for DEK at multiple stages along this complex pathway: rRNA transcription, pre-rRNA processing and transport of pre-ribosomal particles. Most importantly, detailed cellular experiments uncovered the
existence of a previously unknown role for DEK in activation of p53 (TP53) in response to cellular stress via regulation of the localisation of the 5S ribonucleoprotein (RNP). Specifically, our data demonstrated that depletion of DEK leads to ribosomal stress,
resulting in disruption of the nucleolus and the release of the 5S RNP complex to a free pool, which then interacts with MDM2. The released ribonucleo-complexes are then redirected to interact with MDM2 and block the E3 ubiquitin ligase activity of MDM2 towards
p53, thus eliciting p53 activation, which is core to the so-called Impaired Ribosome Biogenesis Checkpoint (IRBC) pathway. Moreover, we defined a direct role for DEK in regulating 5S RNP localisation via specific binding to 5S rRNA, which enables for new perspectives
of the involvement of an oncoprotein in the IRBC pathway, proposing crosstalk between cellular responses to oncogenic and ribotoxic stress.
Collectively, this thesis, for the first time, at least to our knowledge, examined the RNA interactome of human DEK under physiological conditions.
The outcome revealed an unexpected aspect of cellular DEK biology: regulation of the ribosome biogenesis pathway at multiple stages. We now identify DEK as a potential regulator of the central tumour suppressor p53 in p53-intact cells via the IRBC checkpoint
- a prominent anti-cancer barrier. Our findings not only expand the knowledge about this notoriously multifunctional and unique oncogene, yet they also reveal clinically relevant functions which may allow paving the way to new approaches that target DEK for
tumour intervention strategies.